← Back to catalogue

medilog DARWIN2 U

FDA UDI

Class II (US FDA UDI)

by Schiller Corp.

Identity

Trade Name
medilog DARWIN2 U FDA UDI
Generic Name
Electrocardiographic long-term ambulatory recording analyser application software FDA UDI
Device Name
The medilog® DARWIN2 U Holter Analysis is intended for the replay and analysis of ECG data pre-recorded on medilog series ambulatory recorders. FDA UDI
Model / Reference
0.282200 FDA UDI
Description
The medilog® DARWIN2 U Holter Analysis is intended for the replay and analysis of ECG data pre-recorded on medilog series ambulatory recorders. FDA UDI

Identifiers

Catalog Number
0.282200 FDA UDI
Primary DI / UDI-DI
07613365003758 FDA UDI
510(k) Number
K053369 FDA UDI
FDA Product Code
DQK FDA UDI
GMDN Term
Electrocardiographic long-term ambulatory recording analyser application software FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
870.1425 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Electrocardiographic long-term ambulatory recording analyser application software

medilog DARWIN2 U by Schiller Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Electrocardiographic long-term ambulatory recording analyser application software.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Schiller Corp.

Sources (1)

  • FDA UDI 4bff849e-fe07-4460-b9f2-a634108f4e74 36 fields · synced May 30, 2026